SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001867096-23-000139
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:15
Documents
93
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xers-20230930.htm   iXBRL 10-Q 1470701
2 EX-10.1 exhibit101-xerisxconsent.htm EX-10.1 18421
3 EX-31.1 q32023exhibit311.htm EX-31.1 10828
4 EX-31.2 q32023exhibit312.htm EX-31.2 10683
5 EX-32.1 q32023exhibit321.htm EX-32.1 7352
11 exhibit101-xerisxconsent001.jpg GRAPHIC 219471
12 exhibit101-xerisxconsent002.jpg GRAPHIC 218863
13 exhibit101-xerisxconsent003.jpg GRAPHIC 256572
14 exhibit101-xerisxconsent004.jpg GRAPHIC 250527
15 exhibit101-xerisxconsent005.jpg GRAPHIC 248371
16 exhibit101-xerisxconsent006.jpg GRAPHIC 53202
17 exhibit101-xerisxconsent007.jpg GRAPHIC 33887
18 exhibit101-xerisxconsent008.jpg GRAPHIC 25314
19 exhibit101-xerisxconsent009.jpg GRAPHIC 25346
  Complete submission text file 0001867096-23-000139.txt   9100370

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20230930.xsd EX-101.SCH 53669
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20230930_cal.xml EX-101.CAL 82877
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20230930_def.xml EX-101.DEF 297060
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20230930_lab.xml EX-101.LAB 671323
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20230930_pre.xml EX-101.PRE 436508
87 EXTRACTED XBRL INSTANCE DOCUMENT xers-20230930_htm.xml XML 840155
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 871082097 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40880 | Film No.: 231392464
SIC: 2834 Pharmaceutical Preparations